Save ArticleThe cannabis stocks we’ve dug up have all displayed positive quarter-over-quarter revenue growth
SmallCapPower | January 25, 2019: The companies we have selected today have proven to be key players in the marijuana industry. Seizing the countless opportunities the cannabis market has to offer, the four cannabis stocks on our list have reported strong quarter-over-quarter revenue growth as of the three months ended September 30, 2018.
*Share prices as at close January 23, 2019, all data obtained from S&P Capital IQ
CannTrust Holdings Inc. (TSX:TRST) – $8.75
CannTrust Holdings is a producer and distributor of pharmaceutical medical cannabis and related products. With the help of healthcare practitioners, the Company sells dried cannabis and oil extractions to clients. Incorporated in 2015, the Company currently has a 60,000 sq. ft. facility that produces 3,600 kg of cannabis annually. With goals to expand in 2019, CannTrust plans to build a 450,000 sq. ft. facility in the Niagara Region. On January 8, CannTrust announced its application to list on the NYSE.
Cresco Labs Inc. (CSE:CL) – $8.67
Cresco Labs is a vertically-integrated company that engages in the cultivation, manufacturing, and retail of cannabis and related products. The Company’s leading brands include Mindy’s Edibles, Reserve Premium Cannabis, and Remedi Medical. The Company has locations across six states, including Arizona, California, Illinois, Nevada, Ohio and Pennsylvania, and hopes to begin operations in New York, New Jersey, and Massachusetts in 2019. On December 20, Cresco announced it had acquired MedMar Rockford and MedMar Lakeview, two licensed medical cannabis dispensaries.